
While Covid-19 may grab health headlines in the U.S., the opioid epidemic is not going away, and shifting from prescription to synthetic compounds. . . . → Read More: Infographic – Synthetic Opioids Driving Overdose Deaths
|
|||||
![]() While Covid-19 may grab health headlines in the U.S., the opioid epidemic is not going away, and shifting from prescription to synthetic compounds. . . . → Read More: Infographic – Synthetic Opioids Driving Overdose Deaths ![]() A collaboration between developers of protein analytics and test-strip diagnostics aims to create a quicker, more sensitive, easy-to-use Covid-19 detection test. . . . → Read More: Partnership Developing Faster, Sensitive Covid-19 Test ![]() A drug discovery company with an electronic screening process based on semiconductor technology is starting up and raising $9.25 million in seed funds. . . . → Read More: Semiconductor Tech Drug Discovery Company Underway ![]() A clinical trial is underway testing a therapy for opioid use disorder that places a treatment drug pellet under the skin lasting for 12 weeks. . . . → Read More: Trial Begins for Skin-Implanted Addiction Therapy ![]() Synthetic biology developer Ginkgo Bioworks is acquiring agricultural biologics assets from Bayer, transforming the companies’ five-year partnership. . . . → Read More: Ginkgo Acquires Bayer Agricultural Biologics Technology ![]() A developer of new treatments for the inherited lung disease cystic fibrosis emerged from stealth mode, raising $111 million in new venture funds. . . . → Read More: Cystic Fibrosis Start-Up Raises $111M in New Funds ![]() A company that captures and converts greenhouse gases to usable materials with synthetic biology is developing a process to produce aviation fuel. . . . → Read More: Synthetic Bio Harnessed for Jet Fuel from CO2 ![]() Findings from a clinical trial show a rapidly disintegrating cannabidiol tablet reduces pain with few adverse effects in patients having shoulder surgery. . . . → Read More: CBD Tablet Shown to Reduce Post-Operative Pain ![]() A company developing a needle patch for vaccine delivery is acquiring the rights to a synthetic SARS-Cov-2 spike protein for its Covid-19 vaccine patch. . . . → Read More: Univ. Lab Licenses Protein for Vaccine Patch ![]() A biotechnology company discovering protein therapies in fungi is collaborating with drug maker GlaxoSmithKline to find new small molecule drugs. . . . → Read More: Drug Discovery Biotech Inks Partnering Deal, Gains $175M |
|||||
Copyright © 2022 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |